The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
Please Note: Due to volume considerations, not all questions can be answered. Questions most likely to be answered will be those of general interest to a broad group of visitors to this forum. Questions pertaining to a specific case; requests for diagnosis, medical advice, or second opinion; or requests for opinions about untested alternative therapies will generally not be answered.

La participacion del Doctor Steve Natterstad en el Foro de Tratamientos fue hecho posible gracias a Boehringer Ingelheim.

Pregunte a los Expertos sobre Tratamientos del VIH/SIDA

 

que opina de este articulo?
Jan 30, 2006

Hola Doctor! un placer contactarme con Ud dada su franqueza y simpleza de respuestas. en este caso me gustaria saber su opinion sobre este articulo que encontré en la pagina medscape: Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1

Thomas C. Quinn, M.D., Maria J. Wawer, M.D., Nelson Sewankambo, M.B., David Serwadda, M.B., Chuanjun Li, M.D., Fred Wabwire-Mangen, Ph.D., Mary O. Meehan, B.S., Thomas Lutalo, M.A., Ronald H. Gray, M.D., for The Rakai Project Study Group

Full Text PDF

Editorial by Angell, M.

Editorial by Cohen, M. S.

Letters

Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Find Similar Articles PubMed Citation

ABSTRACT

Background and Methods We examined the influence of viral load in relation to other risk factors for the heterosexual transmission of human immunodeficiency virus type 1 (HIV-1). In a community-based study of 15,127 persons in a rural district of Uganda, we identified 415 couples in which one partner was HIV-1positive and one was initially HIV-1negative and followed them prospectively for up to 30 months. The incidence of HIV-1 infection per 100 person-years among the initially seronegative partners was examined in relation to behavioral and biologic variables.

Results The male partner was HIV-1positive in 228 couples, and the female partner was HIV-1positive in 187 couples. Ninety of the 415 initially HIV-1negative partners seroconverted (incidence, 11.8 per 100 person-years). The rate of male-to-female transmission was not significantly different from the rate of female-to-male transmission (12.0 per 100 person-years vs. 11.6 per 100 person-years). The incidence of seroconversion was highest among the partners who were 15 to 19 years of age (15.3 per 100 person-years). The incidence was 16.7 per 100 person-years among 137 uncircumcised male partners, whereas there were no seroconversions among the 50 circumcised male partners (P<0.001). The mean serum HIV-1 RNA level was significantly higher among HIV-1positive subjects whose partners seroconverted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 copies per milliliter, P=0.01). There were no instances of transmission among the 51 subjects with serum HIV-1 RNA levels of less than 1500 copies per milliliter; there was a significant doseresponse relation of increased transmission with increasing viral load. In multivariate analyses of log-transformed HIV-1 RNA levels, each log increment in the viral load was associated with a rate ratio of 2.45 for seroconversion (95 percent confidence interval, 1.85 to 3.26).

Conclusions The viral load is the chief predictor of the risk of heterosexual transmission of HIV-1, and transmission is rare among persons with levels of less than 1500 copies of HIV-1 RNA per milliliter.

Source Information

From the National Institute of Allergy and Infectious Diseases, Bethesda, Md. (T.C.Q.); Johns Hopkins University, Baltimore (T.C.Q., C.L., R.H.G.); Columbia University, New York (M.J.W., M.O.M.); and the Faculty of Medicine, Makerere University, Kampala, Uganda (N.S., D.S., F.W.-M., T.L.).

Address reprint requests to Dr. Quinn at the Division of Infectious Diseases, Johns Hopkins University, 720 Rutland Ave., Ross 1159, Baltimore, MD 21205-2196.

Respuesta del Dr. Santana

Estimado Amigo: Ya habia visto el articulo. El Dr. Quinn es conocido personal y muy serio investigador. En esencia plantea interesantemente algunas cosas ya conocidas dentro de un marco controlado de estudio. Entre otras cosas que la carga viral es un predictor independiente de transmision y que mientras mayor la carga viral mayor el riesgo.Otro punto que presenta es la poca diferencia si alguna, entre la taza de riesgo de transmision entre hombre-mujer, mujer-hombre.Esto no me sorprende ya que demuestra la poblacion cautiva dentro del nucleo relacion familiar y donde uno de los dos es ya positivo para VIH. Un punto que para mi es mas importante es el hecho de ausencia de seroconversion entre los varones circundados vs. los no circundados. Esto tiene para mi una importancia mayor de salud publica ya que en algunas culturas por tradicion ,al varon no se le hace circumsicion y esto pudiese repercutir en un mayor riesgo para infeccion.

Me complace que este buscando informacion relevante y de buena fuente. Lo felicito.

P.S. Por favor, la proxima vez con solo copiarme una vez la misiva es suficiente. Gracias y saludos



Terms of Use
Please remember that this forum is designed for educational purposes only, and experts are not engaged through this forum in rendering legal or medical advice or professional services. Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither The Body nor any sponsor is the publisher or speaker of posted visitors' questions or the experts' material.

Questions and messages posted to this forum are not statements of advice, opinion, or information of The Body, Body Health Resources Corporation or any sponsor of this forum. While neither The Body nor Body Health Resources Corporation regularly reviews posted content, we reserve the right to delete, move, or edit postings if we deem it appropriate under the circumstances. Visitors submitting questions remain solely responsible for the content of their messages.

Information provided by experts is general only and should not be used for diagnosing or treating a health problem or a disease, or relied upon as legal or other professional advice. This information is not a substitute for professional advice or care. If you have or suspect you may have a health or legal problem, you should consult your own health care provider or your attorney.

Copyright notice.